| Issue Date | Title | Author(s) |
| 2014 | Application of a policy framework for the public funding of drugs for rare diseases | Winquist, E; Coyle, D; Clarke, JTR; Evans, GA; Seager, C; Chan, W; Martin, J |
| 2014 | Cost effectiveness of a survivorship care plan for breast cancer survivors | Coyle, D; Grunfeld, E; Coyle, K; Pond, G; Julian, JA; Levine, MN |
| 2017 | Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD | Huber, M; Präger, M; Coyle, K; Coyle, D; Lester-George, A; Trapero-Bertran, M; Nemeth, B; Cheung, KL; Stark, R; Vogl, M; Pokhrel, S; Leidl, R |
| 2013 | Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project | Lord, J; Willis, S; Eatock, J; Tappenden, P; Trapero-Bertran, M; Miners, A; Crossan, C; Westby, M; Anagnostou, A; Taylor, SJE; Mavranezouli, I; Wonderling, D; Alderson, P; Ruiz, F |
| 2006 | Measuring uncertainty in economic evaluations: A case study in liver transplantation | Young, Tracey Anne |
| 2011 | Methods to estimate the cost effectiveness threshold for the NHS | Sculpher, M; HERG Seminar Series |
